February 24, 2014 / 6:36 AM / 4 years ago

BRIEF-Thrombogenics says to explore strategic options for the company

BRUSSELS, Feb 24 (Reuters) - ThromboGenics NV : * To explore strategic options for the company * Decision to increase the company’s ability to realize the significant commercial potential of jetrea in the US * Thr.br-says the board has retained Morgan Stanley to help with the strategic review process

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below